Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery

NCT00798239 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease
Spondylolisthesis

Interventions

DEVICE: Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules
OTHER: Iliac crest autograft
DEVICE: Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules

Sponsor

BioSurface Engineering Technologies, Inc